Molina Healthcare, Inc (NYSE:MOH – Get Free Report) Director Dale Wolf sold 1,600 shares of the business’s stock in a transaction on Friday, November 13th. The shares were sold at an average price of $206.12, for a total transaction of $329,792.00. Following the completion of the sale, the director directly owned 14,337 shares in the company, valued at $2,955,142.44. This represents a 10.04% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Molina Healthcare Stock Down 0.2%
NYSE MOH traded down $0.48 on Friday, reaching $209.37. The company had a trading volume of 362,848 shares, compared to its average volume of 997,807. The firm has a market capitalization of $10.93 billion, a price-to-earnings ratio of -218.09, a price-to-earnings-growth ratio of 12.38 and a beta of 0.75. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.69 and a current ratio of 1.69. Molina Healthcare, Inc has a 1-year low of $121.06 and a 1-year high of $244.89. The company’s fifty day moving average is $202.56 and its 200-day moving average is $185.69.
Molina Healthcare (NYSE:MOH – Get Free Report) last released its quarterly earnings results on Wednesday, October 21st. The company reported $0.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.79 by $0.10. The firm had revenue of $11.08 billion for the quarter, compared to the consensus estimate of $10.86 billion. Molina Healthcare had a positive return on equity of 2.50% and a negative net margin of 0.11%. The company’s revenue for the quarter was down 3.4% on a year-over-year basis. During the same quarter last year, the business posted $1.84 EPS. On average, research analysts forecast that Molina Healthcare, Inc will post 5.30 earnings per share for the current fiscal year.
Molina Healthcare News Summary
These are some of the MOH news items that stood out recently:
- Negative Sentiment: Zacks Research lowered its EPS estimates for Q1 2027 to $2.48 from $2.53, Q3 2027 to $2.17 from $2.23, and Q3 2028 to $3.85 from $4.06. The analyst firm maintained a Hold rating; the downward revisions may weigh on sentiment about Molina’s earnings outlook.
- Negative Sentiment: Three insiders reported selling a combined 10,382 shares for about $2.11 million, reducing their individual holdings by roughly 6% to 12%. These sales may be viewed as a negative signal, though insider transactions alone do not establish a change in the company’s fundamentals. Jeff Barlow SEC filing Richard Schapiro SEC filing Dale Wolf SEC filing
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the stock. Entropy Technologies LP boosted its holdings in shares of Molina Healthcare by 3.5% in the 3rd quarter. Entropy Technologies LP now owns 13,712 shares of the company’s stock valued at $2,593,000 after buying an additional 468 shares during the last quarter. Marshall Wace LLP grew its stake in shares of Molina Healthcare by 703.3% in the third quarter. Marshall Wace LLP now owns 105,801 shares of the company’s stock valued at $20,007,000 after buying an additional 92,630 shares in the last quarter. Beaconlight Capital LLC bought a new position in shares of Molina Healthcare in the third quarter valued at $4,703,000. Empowered Funds LLC increased its holdings in Molina Healthcare by 131.9% during the third quarter. Empowered Funds LLC now owns 112,266 shares of the company’s stock worth $21,230,000 after buying an additional 63,850 shares during the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund increased its holdings in Molina Healthcare by 2,850,000.0% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 57,002 shares of the company’s stock worth $10,779,000 after buying an additional 57,000 shares during the last quarter. 98.50% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of research firms have recently issued reports on MOH. Robert W. Baird set a $198.00 price objective on shares of Molina Healthcare in a report on Friday, October 23rd. Royal Bank Of Canada increased their target price on shares of Molina Healthcare from $218.00 to $222.00 and gave the stock a “sector perform” rating in a report on Friday, October 23rd. Wall Street Zen upgraded shares of Molina Healthcare from a “sell” rating to a “hold” rating in a report on Saturday, October 24th. UBS Group raised their target price on shares of Molina Healthcare from $202.00 to $225.00 and gave the company a “neutral” rating in a research report on Friday, October 23rd. Finally, Mizuho set a $255.00 price target on shares of Molina Healthcare in a research note on Friday, October 23rd. Three equities research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, Molina Healthcare presently has an average rating of “Hold” and an average target price of $213.88.
Get Our Latest Stock Analysis on Molina Healthcare
Molina Healthcare Company Profile
Molina Healthcare, Inc. is a managed care company that provides health insurance plans primarily to people covered by government-sponsored programs. Its offerings include Medicaid plans, Medicare plans for eligible individuals and dual-eligible members, and health plans sold through government marketplaces under the Affordable Care Act. The company was founded in 1980 by physician C. David Molina in Long Beach, California, initially serving low-income families through community clinics. It later shifted its focus to providing managed health care, with Medicaid becoming a central part of its business.
Read More
- Five stocks we like better than Molina Healthcare
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
